US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
DK0693924T4
(da)
*
|
1993-02-22 |
2008-08-04 |
Abraxis Bioscience Inc |
Fremgangsmåde til (in vivo) levering af biologiske materialer og sammensætninger, der er egnede dertil
|
US6749868B1
(en)
*
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US20070122465A1
(en)
*
|
1993-02-22 |
2007-05-31 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
US6143211A
(en)
*
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
US8137684B2
(en)
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CA2294981C
(en)
*
|
1997-06-27 |
2012-04-03 |
Vivorx Pharmaceuticals, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
EP3266450A1
(en)
*
|
1997-06-27 |
2018-01-10 |
Abraxis BioScience, LLC |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
JP4272811B2
(ja)
*
|
1997-09-05 |
2009-06-03 |
マルホ株式会社 |
関節内疾患治療用のナノカプセル製剤
|
HUP9701554D0
(en)
*
|
1997-09-18 |
1997-11-28 |
Human Oltoanyagtermeloe Gyogys |
Pharmaceutical composition containing plazma proteins
|
US6884842B2
(en)
|
1997-10-14 |
2005-04-26 |
Alnis Biosciences, Inc. |
Molecular compounds having complementary surfaces to targets
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
CA2362338A1
(en)
*
|
1998-07-30 |
2000-02-10 |
Human Rt. |
Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
|
GB9820746D0
(en)
†
|
1998-09-23 |
1998-11-18 |
Pharmax Limited |
Micronised pharmaceutical compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
AT406054B
(de)
*
|
1998-11-04 |
2000-02-25 |
Andreas Bernkop-Schnuerch |
Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
DE19856432A1
(de)
*
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
DE19919769A1
(de)
|
1999-04-30 |
2000-11-02 |
Henkel Kgaa |
Verwendung nanoskaliger antimikrobieller Wirkstoffe in Körperdeodorantien
|
GB9910975D0
(en)
*
|
1999-05-13 |
1999-07-14 |
Univ Strathclyde |
Rapid dehydration of proteins
|
CA2371912C
(en)
*
|
1999-05-21 |
2010-02-16 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
GB2350297A
(en)
*
|
1999-05-27 |
2000-11-29 |
Abbott Lab |
Injectable halogenated anesthetic formulation in emulsion form
|
US6610317B2
(en)
*
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19932157A1
(de)
*
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
EP1221968B1
(en)
*
|
1999-10-13 |
2010-01-13 |
Novartis Vaccines and Diagnostics, Inc. |
Method of obtaining cellular immune responses from proteins
|
WO2001049268A1
(en)
*
|
2000-01-05 |
2001-07-12 |
Imarx Therapeutics, Inc. |
Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US20020041898A1
(en)
*
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
GB2359747B
(en)
*
|
2000-02-29 |
2002-04-24 |
Maelor Pharmaceuticals Ltd |
Anaesthetic formulations
|
ATE432063T1
(de)
*
|
2000-03-23 |
2009-06-15 |
Basf Catalysts Llc |
Verfahren zur herstellung von physiologisch aktiven substanzen enthaltenden dispersionen unter anwendung von hochdruck und hochscherkraft
|
ITMI20001107A1
(it)
*
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US6623765B1
(en)
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
AU2001291243A1
(en)
|
2000-09-27 |
2002-04-08 |
Verion Inc. |
Instant water dissolvable encapsulate and process
|
MXPA03002851A
(es)
*
|
2000-10-02 |
2003-07-14 |
Kimberly Clark Co |
Tintas con base de nanoparticula y los metodos para hacer las mismas.
|
BR0115260A
(pt)
|
2000-11-09 |
2005-08-16 |
Neopharm Inc |
Complexos de sn-38 com lipìdeos e seus usos no tratamento de doenças
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US7115565B2
(en)
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
US20040022861A1
(en)
*
|
2001-01-30 |
2004-02-05 |
Williams Robert O. |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
CA2440935A1
(en)
*
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
DE10115740A1
(de)
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
AU2002245979A1
(en)
*
|
2001-04-05 |
2002-10-21 |
Universite Laval |
Process for making protein delivery matrix and uses thereof
|
ES2286244T3
(es)
*
|
2001-04-20 |
2007-12-01 |
The University Of British Columbia |
Sistemas de suministro de farmaco micelar para farmacos hirofobicos.
|
SG126676A1
(en)
*
|
2001-05-09 |
2007-01-30 |
Nanomaterials Tech Pte Ltd |
Process for the controlled production of organic particles
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
CA2451187C
(en)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
GB0116074D0
(en)
*
|
2001-06-29 |
2001-08-22 |
Univ Strathclyde |
Nanoparticle structures
|
US20040013698A1
(en)
*
|
2001-07-09 |
2004-01-22 |
Aust Duncan T |
Method for preparing topical preparations containing skin protective agents with enhanced barrier properties
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
TWI252847B
(en)
*
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
TWI332943B
(en)
*
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
US20040018250A1
(en)
*
|
2001-07-11 |
2004-01-29 |
Ceccoli Joseph D. |
Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solids and oils
|
WO2003013683A1
(en)
*
|
2001-08-08 |
2003-02-20 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
US20030199587A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique Cmax properties
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
BR0212833A
(pt)
*
|
2001-09-26 |
2004-10-13 |
Baxter Int |
Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
|
IL160927A0
(en)
*
|
2001-10-15 |
2004-08-31 |
Crititech Inc |
Compositions and methods for delivery of poorly water soluble drugs and method of treatment
|
US20040015519A1
(en)
*
|
2001-10-15 |
2004-01-22 |
Yukitoshi Maeda |
Content delivery server and content delivery system having the same
|
PL210795B1
(pl)
|
2001-10-19 |
2012-03-30 |
Isotechnika Inc |
Sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (E), sposób wytwarzania mieszaniny ISATX247 wzbogaconej w izomer (Z), sposób stereoselektywnej syntezy izomeru (E) ISATX247, sposób stereoselektywnej syntezy izomeru (Z) ISATX247 i sposób wytwarzania mieszaniny izomerów ISATX247
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
WO2003037359A1
(fr)
*
|
2001-10-29 |
2003-05-08 |
Chengdu Somo Namotechnology Co., Ltd. |
Nanoparticule de composants de medicaments insolubles et procede de production correspondant
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
ATE464880T1
(de)
*
|
2002-02-04 |
2010-05-15 |
Elan Pharma Int Ltd |
Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
CA2479665C
(en)
†
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
AU2003224808A1
(en)
*
|
2002-03-28 |
2003-10-13 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
ITMI20020681A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
ITMI20020680A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
AU2003263024A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Christopher Mcconville |
Process of forming and modifying particles and compositions produced thereby
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
EP2324866B1
(en)
*
|
2002-07-12 |
2014-06-18 |
Cook Medical Technologies LLC |
Angioplasty balloons drug-coated in an expanded condition
|
DK1521572T3
(da)
*
|
2002-07-15 |
2009-05-04 |
Alcon Inc |
Biologisk nedbrydelig film til indförsel af öjenlægemiddel
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
GB0216700D0
(en)
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
DE10234165B4
(de)
*
|
2002-07-26 |
2008-01-03 |
Advanced Micro Devices, Inc., Sunnyvale |
Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
|
ATE442130T1
(de)
|
2002-08-12 |
2009-09-15 |
Bend Res Inc |
Arzneizubereitungen bestehend aus arzneimitteln in halb-geordneter form und polymeren
|
WO2004035032A2
(en)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
US7090868B2
(en)
*
|
2002-09-13 |
2006-08-15 |
University Of Florida |
Materials and methods for drug delivery and uptake
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
DE10244847A1
(de)
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
AU2002342808A1
(en)
*
|
2002-10-09 |
2004-05-04 |
Unibioscreen S.A. |
Extract with anti-tumor and anti-poisonous activity
|
EP1556011A1
(en)
*
|
2002-10-28 |
2005-07-27 |
Polymerix Corporation |
Therapeutic compositions
|
WO2004098570A1
(en)
*
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
JP2006508126A
(ja)
*
|
2002-11-06 |
2006-03-09 |
アザヤ セラピューティクス インコーポレイティッド |
薬学的製剤のタンパク質安定化されたリポソーム製剤
|
WO2004045494A2
(en)
*
|
2002-11-20 |
2004-06-03 |
Bar-Ilan University |
Biological glue based on thrombin-conjugated nanoparticles
|
RU2361615C2
(ru)
*
|
2002-12-09 |
2009-07-20 |
Абраксис Байосайенс, Ллс. |
Композиции и способы доставки фармакологических агентов
|
BR0317134A
(pt)
*
|
2002-12-09 |
2005-11-22 |
American Bioscience Inc |
Composições e métodos de liberação de agentes farmacológicos
|
JP2006524632A
(ja)
*
|
2002-12-09 |
2006-11-02 |
アメリカン バイオサイエンス、インコーポレイテッド |
組成物及び薬物送達方法
|
US7666410B2
(en)
|
2002-12-20 |
2010-02-23 |
Kimberly-Clark Worldwide, Inc. |
Delivery system for functional compounds
|
US8409618B2
(en)
|
2002-12-20 |
2013-04-02 |
Kimberly-Clark Worldwide, Inc. |
Odor-reducing quinone compounds
|
US6780896B2
(en)
*
|
2002-12-20 |
2004-08-24 |
Kimberly-Clark Worldwide, Inc. |
Stabilized photoinitiators and applications thereof
|
TWI330079B
(en)
*
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
DE60311958T2
(de)
*
|
2003-02-03 |
2007-11-08 |
Polaschegg, Hans-Dietrich, Dr. |
Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US7968115B2
(en)
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
WO2004080396A2
(en)
*
|
2003-03-07 |
2004-09-23 |
The University Of Texas Md Anderson Cancer Center |
Liposomal curcumin for treatment of cancer
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
JP2007507432A
(ja)
*
|
2003-10-02 |
2007-03-29 |
セムバイオシス ジェネティクス インコーポレイテッド |
活性成分を含む油体を調製するための方法
|
US7837663B2
(en)
*
|
2003-10-16 |
2010-11-23 |
Kimberly-Clark Worldwide, Inc. |
Odor controlling article including a visual indicating device for monitoring odor absorption
|
US7794737B2
(en)
|
2003-10-16 |
2010-09-14 |
Kimberly-Clark Worldwide, Inc. |
Odor absorbing extrudates
|
US7488520B2
(en)
|
2003-10-16 |
2009-02-10 |
Kimberly-Clark Worldwide, Inc. |
High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
|
US7754197B2
(en)
|
2003-10-16 |
2010-07-13 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using coordinated polydentate compounds
|
US7413550B2
(en)
|
2003-10-16 |
2008-08-19 |
Kimberly-Clark Worldwide, Inc. |
Visual indicating device for bad breath
|
US7438875B2
(en)
*
|
2003-10-16 |
2008-10-21 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using metal-modified silica particles
|
US7879350B2
(en)
*
|
2003-10-16 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using colloidal nanoparticles
|
US7678367B2
(en)
|
2003-10-16 |
2010-03-16 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using metal-modified particles
|
US7700612B2
(en)
*
|
2003-12-23 |
2010-04-20 |
Abraxis Bioscience, Llc |
Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
|
US20070185217A1
(en)
*
|
2003-12-23 |
2007-08-09 |
Abraxis Bioscience, Inc. |
Propofol analogs, process for their preparation, and methods of use
|
EP1701718A4
(en)
*
|
2003-12-23 |
2009-06-24 |
Abraxis Bioscience Llc |
SUBSTITUTED MELATONIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND METHOD OF ADMINISTRATION
|
US20050186230A1
(en)
*
|
2004-01-23 |
2005-08-25 |
Sd Pharmaceuticals, Inc. |
Elemene compositions containing liquid oil
|
WO2005072710A2
(en)
*
|
2004-01-28 |
2005-08-11 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
JP2007520555A
(ja)
*
|
2004-02-05 |
2007-07-26 |
バクスター・インターナショナル・インコーポレイテッド |
自己安定化剤の使用により調製された分散剤
|
US8784881B2
(en)
*
|
2004-03-05 |
2014-07-22 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of diseases
|
US20080103213A1
(en)
*
|
2004-03-05 |
2008-05-01 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of neurofibromatosis
|
CA2562731A1
(en)
*
|
2004-04-13 |
2005-11-03 |
Alza Corporation |
Apparatus and method for transdermal delivery of fentanyl-based agents
|
CA2469339A1
(en)
*
|
2004-06-07 |
2005-12-07 |
Bernard Charles Sherman |
Sustained release propafenone hydrochloride capsules
|
EP2305642A3
(en)
|
2004-06-23 |
2011-12-14 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amide) salts for treatment of cancers
|
JP4433918B2
(ja)
*
|
2004-07-15 |
2010-03-17 |
コニカミノルタエムジー株式会社 |
画像形成方法
|
KR100578382B1
(ko)
|
2004-07-16 |
2006-05-11 |
나재운 |
항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
BRPI0519088A2
(pt)
*
|
2004-12-15 |
2008-12-23 |
Elan Pharma Int Ltd |
formulaÇÕes de tacrolimo nanoparticuladas
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US8026275B2
(en)
|
2005-02-18 |
2011-09-27 |
Abraxis Bioscience, Llc |
Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
|
KR101914254B1
(ko)
|
2005-02-18 |
2018-11-02 |
아브락시스 바이오사이언스, 엘엘씨 |
치료제의 조합 및 투여 방식, 및 조합 요법
|
US8415388B2
(en)
|
2005-02-22 |
2013-04-09 |
Savvipharm Inc. |
Pharmaceutical compositions containing paclitaxel orotate
|
BRPI0606282A2
(pt)
*
|
2005-03-17 |
2009-06-09 |
Elan Pharma Int Ltd |
composições injetáveis de compostos imunossupressores em nanopartìculas
|
US7722581B2
(en)
*
|
2005-04-11 |
2010-05-25 |
Gholam A. Peyman |
Crystalline lens drug delivery
|
US20060229585A1
(en)
*
|
2005-04-11 |
2006-10-12 |
Minu, L.L.C. |
Drug delivery to the crystalline lens and other ocular structures
|
BRPI0607537A2
(pt)
|
2005-04-12 |
2009-09-15 |
Elan Pharma Int Ltd |
formulações de derivado de quinazolina nanoparticulado
|
CA2604907A1
(en)
*
|
2005-04-15 |
2006-10-26 |
Synta Pharmaceuticals Corp. |
Combination cancer therapy with bis(thiohydrazide) amide compounds
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
MX2007015183A
(es)
*
|
2005-06-14 |
2008-02-19 |
Baxter Int |
Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
|
NZ592132A
(en)
*
|
2005-08-31 |
2012-12-21 |
Abraxis Bioscience Llc |
Composition comprising nanoparticles of docitaxel and a citrate
|
EP2404594B1
(en)
*
|
2005-08-31 |
2017-12-20 |
Abraxis BioScience, LLC |
Compositions comprising docetaxel with increased stability
|
JP5116108B2
(ja)
*
|
2005-09-09 |
2013-01-09 |
トクレ チョン, |
抗癌剤の伝達体用水溶性キトサンナノ粒子及びその製造方法
|
US20070098802A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Isaac Farr |
Organic nanoparticles and associated methods
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
CA2631714C
(en)
|
2005-12-02 |
2014-09-16 |
Novartis Ag |
Nanoparticles for use in immunogenic compositions
|
DE102005062440B4
(de)
*
|
2005-12-27 |
2011-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen
|
KR20080091158A
(ko)
|
2005-12-28 |
2008-10-09 |
다브르 파마 리미티드 |
나노 입자형 약제학적 조성물용으로 유용한, 생혼화성이고비생분해성이며 비독성인 중합체
|
SE529040C2
(sv)
|
2006-01-18 |
2007-04-17 |
Bows Pharmaceuticals Ag |
Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
JP4974533B2
(ja)
*
|
2006-01-30 |
2012-07-11 |
富士フイルム株式会社 |
ジスルフィド架橋したタンパク質ナノ粒子
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
US8728527B2
(en)
*
|
2006-07-24 |
2014-05-20 |
Luminus Biosciences, Inc. |
Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
|
AU2007288338B2
(en)
|
2006-08-21 |
2012-05-03 |
Synta Pharmaceuticals Corp. |
Compounds for treating proliferative disorders
|
AU2007290490B2
(en)
*
|
2006-08-31 |
2011-09-08 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
WO2008030557A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
US9498528B2
(en)
*
|
2006-09-13 |
2016-11-22 |
Genzyme Corporation |
Treatment of multiple sclerosis (MS)
|
AR063704A1
(es)
|
2006-09-14 |
2009-02-11 |
Makhteshim Chem Works Ltd |
Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
|
US20110021592A1
(en)
*
|
2006-09-14 |
2011-01-27 |
Shlomo Magdassi |
Organic nanoparticles obtained from microemulsions by solvent evaporation
|
JP2010504359A
(ja)
|
2006-09-20 |
2010-02-12 |
ザ ボード オブ リージェンツ オブ ザ ユニバーシティー オブ テキサス システム |
局部麻酔および/または疼痛緩和のための、揮発性麻酔剤を送達するための方法
|
JP5099545B2
(ja)
*
|
2006-10-17 |
2012-12-19 |
公立大学法人大阪府立大学 |
化合物の溶解補助剤とそれを含む組成物
|
PT2091919E
(pt)
*
|
2006-11-15 |
2011-09-05 |
Abraxis Bioscience Llc |
Derivados de análogos de hidroquinona de geldamicina substituídos por 18-amino que apresentam atividade citotóxica para o tratamento de cancro.
|
US7799954B2
(en)
*
|
2006-11-17 |
2010-09-21 |
Abraxis Bioscience, Llc |
Dicarbonyl derivatives and methods of use
|
US9675578B2
(en)
|
2006-12-14 |
2017-06-13 |
Abraxis Bioscience, Llc |
Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane
|
AU2007333925B2
(en)
*
|
2006-12-15 |
2013-10-31 |
Nantbio, Inc. |
Triazine derivatives and their therapeutical applications
|
DK2481402T3
(da)
|
2007-03-07 |
2018-08-06 |
Abraxis Bioscience Llc |
Nanopartikel, der omfatter rapamycin og albumin som middel mod cancer
|
EP2146707A2
(en)
|
2007-05-03 |
2010-01-27 |
Abraxis BioScience, LLC |
Methods and compositions for treating pulmonary hypertension
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
ES2435452T3
(es)
*
|
2007-06-01 |
2013-12-19 |
Abraxis Bioscience, Llc |
Métodos y composiciones para tratar un cáncer recurrente
|
JP2010539245A
(ja)
*
|
2007-09-14 |
2010-12-16 |
日東電工株式会社 |
薬物担体
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
DK2244737T3
(da)
|
2008-01-22 |
2019-07-08 |
Univ Texas |
Flygtige anæstetiske sammensætninger omfattende ekstraktionsopløsningsmidler til regional anæstesi og/eller smertelindring
|
MX2010011165A
(es)
*
|
2008-04-10 |
2011-02-22 |
Abraxis Bioscience Llc |
Composiciones de derivados de taxano hidrofobos y sus usos.
|
TW200942233A
(en)
*
|
2008-04-10 |
2009-10-16 |
Abraxis Bioscience Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
US9126025B2
(en)
*
|
2008-05-01 |
2015-09-08 |
Bayer Intellectual Property Gmbh |
Method of coating a folded catheter balloon
|
CN101658516B
(zh)
*
|
2008-08-26 |
2011-10-05 |
齐鲁制药有限公司 |
紫杉醇类药物组合物及其制备方法
|
NZ593343A
(en)
|
2008-12-11 |
2013-04-26 |
Abraxis Bioscience Llc |
Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
|
CA2755121A1
(en)
|
2009-03-13 |
2010-09-16 |
Neil P. Desai |
Combination therapy with thiocolchicine derivatives
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
ME03596B
(me)
|
2009-04-15 |
2020-07-20 |
Abraxis Bioscience Llc |
Kompozicije nanočesтica bez priona i postupci povezani sa njima
|
AU2010258800B2
(en)
|
2009-06-09 |
2013-10-10 |
Nantbio, Inc. |
Isoquinoline, quinoline, and quinazoline derivatives as inhibitors of hedgehog signaling
|
WO2010144394A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Benzyl substituted triazine derivatives and their therapeutical applications
|
WO2010144550A1
(en)
|
2009-06-09 |
2010-12-16 |
Abraxis Bioscience, Llc |
Triazine derivatives and their therapeutical applications
|
CN101653611B
(zh)
*
|
2009-07-23 |
2012-05-09 |
复旦大学 |
一种白蛋白-阿霉素纳米制剂及其制备方法和应用
|
WO2011017835A1
(en)
*
|
2009-08-11 |
2011-02-17 |
Nanjing University |
Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
|
UA110196C2
(uk)
|
2009-08-25 |
2015-12-10 |
Абраксіс Байосайєнс, Елелсі |
Комбінована терапія композиціями наночастинок таксану і інгібіторами хеджхог
|
US10350364B2
(en)
|
2009-11-11 |
2019-07-16 |
Windgap Medical, Inc. |
Portable Drug Mixing and Delivery Device and Associated Methods
|
US9211283B2
(en)
|
2009-12-11 |
2015-12-15 |
Biolitec Pharma Marketing Ltd |
Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
|
WO2011097149A2
(en)
*
|
2010-02-03 |
2011-08-11 |
Oncbiomune, L.L.C. |
Taxane-and taxoid-protein compositions
|
ES2675212T3
(es)
|
2010-03-26 |
2018-07-09 |
Abraxis Bioscience, Llc |
Métodos de tratamiento de carcinoma hepatocelular
|
MX2012011155A
(es)
|
2010-03-29 |
2012-12-05 |
Abraxis Bioscience Llc |
Metodos para mejorar suministros de farmacos y efectividad de agentes terapeuticos.
|
DK2552415T3
(da)
|
2010-03-29 |
2016-11-28 |
Abraxis Bioscience Llc |
Fremgangsmåder til behandling af cancer
|
US20110262347A1
(en)
|
2010-04-08 |
2011-10-27 |
The Salk Institute For Biological Studies |
Methods and compositions for enhanced delivery of compounds
|
CN103221042B
(zh)
|
2010-06-02 |
2016-02-10 |
阿布拉科斯生物科学有限公司 |
治疗膀胱癌的方法
|
CN103140225A
(zh)
|
2010-06-04 |
2013-06-05 |
阿布拉科斯生物科学有限公司 |
治疗胰腺癌的方法
|
SG185798A1
(en)
|
2010-06-07 |
2013-01-30 |
Abraxis Bioscience Llc |
Combination therapy methods for treating proliferative diseases
|
CN103202812B
(zh)
*
|
2010-08-09 |
2015-10-28 |
南京大学 |
一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
|
CN103202813B
(zh)
*
|
2010-08-09 |
2015-09-30 |
南京大学 |
一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
|
KR101223484B1
(ko)
|
2010-10-05 |
2013-01-17 |
한국과학기술연구원 |
사람 혈청 알부민-siRNA 나노입자 전달체
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
US9808030B2
(en)
|
2011-02-11 |
2017-11-07 |
Grain Processing Corporation |
Salt composition
|
WO2012118778A1
(en)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Truncated car peptides and methods and compositions using truncated car peptides
|
RU2475247C2
(ru)
*
|
2011-03-05 |
2013-02-20 |
Республика Северная Осетия-Алания "Всероссийское общество изобретателей и рационализаторов" ("ВОИР") |
Способ профилактики несостоятельности кишечного анастомоза
|
CN102133190A
(zh)
*
|
2011-03-16 |
2011-07-27 |
中国药科大学 |
一种转铁蛋白纳米粒及其制备方法和用途
|
CO6540157A1
(es)
|
2011-04-15 |
2012-10-16 |
Univ Antioquia |
Proceso continuo para la elaboracion de nanoparticulas y nanoparticulas obtenidas mediante dicho proceso
|
KR20200051841A
(ko)
|
2011-04-28 |
2020-05-13 |
아브락시스 바이오사이언스, 엘엘씨 |
나노입자 조성물의 혈관내 전달 및 그의 용도
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
CN104168884A
(zh)
|
2011-11-01 |
2014-11-26 |
细胞基因公司 |
使用胞苷类似物的口服制剂治疗癌症的方法
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
WO2013084207A1
(pt)
|
2011-12-07 |
2013-06-13 |
Universidade Do Minho |
Formulações micelares proteicas e respectivo método de produção
|
RU2499991C2
(ru)
*
|
2011-12-14 |
2013-11-27 |
Государственное бюджетное образовательное учреждение высшего профессионального образования "Северный государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации |
Способ дифференциальной диагностики типа гепаторенального синдрома алкогольного генеза
|
DK2790675T3
(da)
|
2011-12-14 |
2019-09-09 |
Abraxis Bioscience Llc |
Anvendelse af polymerexcipienser til frysetørring eller frysning af partikler
|
EP2844227B1
(en)
|
2012-05-03 |
2020-11-18 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
EP4008355A1
(en)
|
2012-05-03 |
2022-06-08 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
BR112015001838B1
(pt)
|
2012-07-27 |
2022-10-25 |
Izumi Technology, Llc |
Composição de inibidor de efluxo
|
RU2674249C2
(ru)
|
2012-11-05 |
2018-12-06 |
НэнтБайо, Инк. |
Замещенные производные индол-5-ола и их терапевтическое применение
|
WO2014071298A1
(en)
|
2012-11-05 |
2014-05-08 |
Nant Holdings Ip, Llc |
Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
WO2014078435A1
(en)
*
|
2012-11-14 |
2014-05-22 |
W. R. Grace & Co.-Conn. |
Compositions containing a biologically active material and a non-ordered inorganic oxide
|
JP5999765B2
(ja)
*
|
2012-12-07 |
2016-09-28 |
バイオアバイラビリティ,インク. |
栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムq10調製物
|
PT106738B
(pt)
*
|
2013-01-09 |
2015-06-08 |
Hovione Farmaciencia Sa |
Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
MX2015010312A
(es)
|
2013-02-11 |
2015-11-18 |
Abraxis Bioscience Llc |
Metodos para tratamiento del melanoma.
|
ITBN20130001A1
(it)
*
|
2013-02-19 |
2014-08-20 |
Prodal S C A R L |
Particelle biopolimeriche sub-micrometriche per la veicolazione di composti attivi in campo alimentare, farmaceutico e cosmetico e procedimento per la loro preparazioneparticelle biopolimeriche sub-micrometriche per la veicolazione di composti attivi
|
JP6349381B2
(ja)
|
2013-03-12 |
2018-06-27 |
アブラクシス バイオサイエンス, エルエルシー |
肺がんを処置する方法
|
KR20150126671A
(ko)
|
2013-03-13 |
2015-11-12 |
아브락시스 바이오사이언스, 엘엘씨 |
소아 고형 종양의 치료 방법
|
US9962373B2
(en)
|
2013-03-14 |
2018-05-08 |
Abraxis Bioscience, Llc |
Methods of treating bladder cancer
|
US20150367073A1
(en)
|
2013-03-15 |
2015-12-24 |
Windgap Medical, Llc |
Portable Drug Mixing and Delivery Device and Associated Methods
|
US10569017B2
(en)
|
2013-03-15 |
2020-02-25 |
Windgap Medical, Inc. |
Portable drug mixing and delivery device and associated methods
|
JP6560187B2
(ja)
|
2013-03-15 |
2019-08-14 |
ウインドギャップ メディカル インコーポレイテッド |
携帯型薬剤混合及び送達システム並びに方法
|
RU2017141536A
(ru)
|
2013-03-15 |
2019-02-13 |
Нэнтбайосайенс, Инк. |
Замещенные производные индол-5-ола и их терапевтические применения
|
US9907910B2
(en)
|
2013-03-15 |
2018-03-06 |
Windgap Medical, Inc. |
Portable drug mixing and delivery device and associated methods
|
KR101329646B1
(ko)
|
2013-05-02 |
2013-11-14 |
주식회사 지니스 |
표적지향증폭형 항암나노입자 및 이의 제조방법
|
CN103393632B
(zh)
*
|
2013-07-26 |
2015-05-13 |
齐鲁制药(海南)有限公司 |
一种卡巴他赛药物组合物及其制备方法
|
CN104368007A
(zh)
*
|
2013-08-12 |
2015-02-25 |
于湛 |
可注射蛋白基花样结构载药微纳材料与内耳跨膜给药缓释制剂及其制备方法
|
KR20150047336A
(ko)
|
2013-10-24 |
2015-05-04 |
삼성전자주식회사 |
나노입자, 이를 제조하는 방법, 및 이의 용도
|
CN104758942A
(zh)
*
|
2014-01-02 |
2015-07-08 |
国家纳米科学中心 |
基于蛋白质的药理活性物质组合物及其制备方法和应用
|
CN103705469B
(zh)
*
|
2014-01-03 |
2016-01-20 |
中国医学科学院药用植物研究所 |
一种和厚朴酚纳米粒及其制备方法
|
JP6280996B2
(ja)
*
|
2014-02-14 |
2018-02-14 |
ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. |
治療剤の放出を伴う急速分解性塞栓粒子および同塞栓粒子を含む医療用組成物
|
CN103861115B
(zh)
*
|
2014-03-18 |
2017-04-19 |
常州市第一人民医院 |
一种血红蛋白纳米粒及其制备方法
|
WO2015195634A1
(en)
|
2014-06-17 |
2015-12-23 |
Celgne Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
CN104434808A
(zh)
|
2014-07-03 |
2015-03-25 |
石药集团中奇制药技术(石家庄)有限公司 |
一种治疗性纳米粒子及其制备方法
|
US11116903B2
(en)
|
2014-08-18 |
2021-09-14 |
Windgap Medical, Inc |
Compression seal for use with a liquid component storage vial of an auto-injector
|
JP6655845B2
(ja)
*
|
2014-12-05 |
2020-02-26 |
国立大学法人神戸大学 |
in vivoステルス性ナノ粒子
|
CN105727303B
(zh)
*
|
2014-12-12 |
2019-06-28 |
四川科伦药物研究院有限公司 |
一种高载卡巴他赛药物的白蛋白组合物及其制剂和制备方法
|
CN104490797A
(zh)
*
|
2014-12-22 |
2015-04-08 |
深圳海王药业有限公司 |
一种多相稳定的白蛋白结合型卡巴他塞
|
WO2016137506A1
(en)
|
2015-02-27 |
2016-09-01 |
Nantbioscience, Inc. |
Pyrimidine derivatives as kinase inhibitors and their therapeutical applications
|
US10527604B1
(en)
*
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
CN106137969B
(zh)
*
|
2015-04-03 |
2020-05-15 |
四川科伦药物研究院有限公司 |
多西他赛白蛋白纳米粒药物组合物及其制备方法及应用
|
JP6606274B2
(ja)
|
2015-04-15 |
2019-11-13 |
ウィンドギャップ メディカル, インコーポレイテッド |
オートインジェクタアセンブリに使用される取り外し可能作動用キャップ
|
JP6983660B2
(ja)
*
|
2015-05-08 |
2021-12-17 |
スペクトラル プラットフォームス インコーポレイテッド |
アルブミンに基づく非共有結合性複合体およびその使用方法
|
US20160346221A1
(en)
|
2015-06-01 |
2016-12-01 |
Autotelic Llc |
Phospholipid-coated therapeutic agent nanoparticles and related methods
|
EP3313447A2
(en)
|
2015-06-25 |
2018-05-02 |
Sanford Burnham Prebys Medical Discovery Institute |
Compositions for delivery to and treatment of atherosclerotic plaques
|
SG10202107198SA
(en)
|
2015-06-29 |
2021-08-30 |
Abraxis Bioscience Llc |
Methods of treating epithelioid cell tumors
|
AU2016306797B2
(en)
|
2015-08-13 |
2021-05-20 |
Windgap Medical, Inc |
Mixing and injection device with sterility features
|
CN105055341A
(zh)
*
|
2015-08-13 |
2015-11-18 |
黑龙江泰华源生物技术有限责任公司 |
一种紫杉醇白蛋白结合型冻干制剂及其制备方法
|
CN105816885A
(zh)
*
|
2016-04-15 |
2016-08-03 |
北京大学 |
一种药物白蛋白纳米粒的制备及其应用方法
|
JP7094226B2
(ja)
*
|
2016-04-29 |
2022-07-01 |
ルスロ・ベー・フェー |
医薬品有効成分用のタンパク質をベースにした添加物
|
BE1023653B1
(nl)
*
|
2016-04-29 |
2017-06-07 |
Rousselot B.V. |
Eiwit gebaseerd excipient voor actieve farmaceutische stoffen
|
CN105944109B
(zh)
*
|
2016-05-03 |
2019-06-11 |
四川大学 |
一种肾小球靶向的蛋白纳米颗粒药物组合物及其用途
|
CN106310221B
(zh)
*
|
2016-08-25 |
2019-11-22 |
齐鲁制药有限公司 |
一种含有卡非佐米的药物组合物及其制备方法
|
WO2018048958A1
(en)
|
2016-09-06 |
2018-03-15 |
Mayo Foundation For Medical Education And Research |
Paclitaxel-albumin-binding agent compositions and methods for using and making the same
|
JP2019533665A
(ja)
*
|
2016-10-10 |
2019-11-21 |
アブラクシス バイオサイエンス, エルエルシー |
ナノ粒子製剤ならびにその作製方法および使用方法
|
PL3548001T3
(pl)
*
|
2016-11-30 |
2022-07-11 |
Dukebox Sp. Z O.O. |
Sposób wytwarzania roztworu nanocząstek kwasu acetylosalicylowego albo diosminy albo drotaweryny
|
EP3602065A4
(en)
|
2017-03-20 |
2020-12-23 |
Spectral Platforms, Inc. |
SPECTROSCOPIC METHODS OF DETECTION AND CHARACTERIZATION OF MICROORGANISMS
|
CN110753541A
(zh)
*
|
2017-04-24 |
2020-02-04 |
Zy治疗公司 |
用于体内递送的药物组合物、基本上不溶于水的药理学活性剂的制备方法
|
CN107412783B
(zh)
*
|
2017-04-28 |
2020-09-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种包裹有难溶于水药物的蛋白质颗粒的制备方法
|
WO2018204392A1
(en)
|
2017-05-02 |
2018-11-08 |
Stanford Burnham Prebys Medical Discovery Institute |
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
|
US10738033B2
(en)
|
2017-05-31 |
2020-08-11 |
Nantbio, Inc. |
Trk inhibition
|
US10800760B2
(en)
|
2017-05-31 |
2020-10-13 |
Nantbio, Inc. |
Trk inhibition
|
WO2019016692A1
(en)
*
|
2017-07-21 |
2019-01-24 |
Emcure Pharmaceuticals Limited |
PARTICLE SIZE STABILIZATION OF PROTEIN-RELATED PARTICLES AND RELATED METHODS
|
CN107412172A
(zh)
*
|
2017-08-04 |
2017-12-01 |
南京拉克森生物医药科技有限公司 |
一种紫杉醇白蛋白纳米混悬剂冻干粉及其制备工艺
|
AU2018321260A1
(en)
*
|
2017-08-25 |
2020-03-05 |
Y. Joseph Mo |
Compositions and methods of delivery of pharmacological agents
|
CN111918652A
(zh)
|
2017-11-06 |
2020-11-10 |
拉普特医疗公司 |
用于治疗eb病毒阳性的癌症的趋化因子受体调节剂
|
JP2021528362A
(ja)
|
2018-03-20 |
2021-10-21 |
アブラクシス バイオサイエンス, エルエルシー |
mTOR阻害剤およびアルブミンのナノ粒子の投与を介して中枢神経系障害を処置する方法
|
CN108524452A
(zh)
*
|
2018-05-08 |
2018-09-14 |
辽宁大学 |
一种紫杉醇白蛋白纳米粒的制备方法和应用
|
AU2019274516A1
(en)
|
2018-05-22 |
2020-12-17 |
Abraxis Bioscience, Llc |
Methods and compositions for treating pulmonary hypertension
|
CN113905722A
(zh)
*
|
2019-01-22 |
2022-01-07 |
锐创生物医药(香港)有限公司 |
白蛋白纳米颗粒、其制备方法和用途
|
EP3921329A1
(en)
|
2019-02-04 |
2021-12-15 |
University of Tartu |
Bi-specific extracellular matrix binding peptides and methods of use thereof
|
US20220218789A1
(en)
|
2019-05-10 |
2022-07-14 |
Nant Holdings Ip, Llc |
Nogapendekin Alfa-Inbakicept For Immune Stimulant Therapies And Treatment Of Viral Infections
|
CN115003284A
(zh)
|
2019-10-28 |
2022-09-02 |
阿布拉科斯生物科学有限公司 |
白蛋白和雷帕霉素的药物组合物
|
US11318189B1
(en)
|
2020-05-13 |
2022-05-03 |
Nantcell, Inc. |
IL-15 agonist drug combinations for immune therapy
|
CN114681408B
(zh)
*
|
2020-12-26 |
2023-06-23 |
四川汇宇制药股份有限公司 |
白蛋白结合型紫杉醇纳米粒的制备方法
|
EP4036580A1
(en)
*
|
2021-02-01 |
2022-08-03 |
Oxford University Innovation Limited |
Drug loaded cavitation agent
|
EP4035655A1
(en)
*
|
2021-02-01 |
2022-08-03 |
Oxford University Innovation Limited |
Immune modulating particles
|
WO2024081674A1
(en)
|
2022-10-11 |
2024-04-18 |
Aadi Bioscience, Inc. |
Combination therapies for the treatment of cancer
|